Skip to main content
Equibles
SIGA logo

SIGA · Siga Technologies Inc · Metrics

Track SIGA — free

Use SIGA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research SIGA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.12 -0.03 (-0.95%) At close · Oct 21
Russell 2000 member Rebalance outlook locked
Market Cap
$226.33M
Shares
71.85M
Volume · Oct 21 267.55K Avg daily vol (3M) 715.38K

SIGA metrics

101 of 122 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.12
Market cap
$226.33M

Price action

20 metrics
Price change (1W)
+0.6%
Price change (30D)
-4.3%
Price change (3M)
-8.0%
Price change (6M)
-30.8%
Price change (YTD)
-48.9%
Price change (1Y)
-63.2%
Trailing year
Price change (5Y)
-55.6%
52-week high
$8.47
52-week low
$2.87
Change from 52-week high
-63.2%
Change from 52-week low
+8.7%
Annualized volatility
46.9%
Annualized volatility (3M)
45.8%
Beta
0.6
RSI (14D)
44.1
Price vs SMA 50
-1.2%
Price vs SMA 200
-30.7%
Avg volume (3M)
715,384
Relative volume
0.4
Average dollar volume
$2.26M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
71.85M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
2.0×
reciprocal yield 49.3%
EV / EBITDA
—
EV / EBIT
—
P / sales
4.2×
reciprocal yield 23.7%
P / book
1.4
reciprocal yield 73.0%
FCF yield
—
TTM · current market cap
Buyback yield
0.0%
P / FCF
—
P / operating cash flow
—
Earnings yield
-1.2%

Historical valuation

8 metrics
P / E historical average (3Y)
9.8×
reciprocal yield 10.2%
P / E historical average (5Y)
11.9×
reciprocal yield 8.4%
EV / revenue historical average (3Y)
2.9×
reciprocal yield 34.7%
EV / revenue historical average (5Y)
3.4×
reciprocal yield 29.3%
EV / EBIT historical average (3Y)
5.7×
reciprocal yield 17.4%
EV / EBIT historical average (5Y)
7.0×
reciprocal yield 14.4%
EV / EBITDA historical average (3Y)
5.7×
reciprocal yield 17.5%
EV / EBITDA historical average (5Y)
7.2×
reciprocal yield 13.8%

Dividends & buybacks

7 metrics
Dividend yield
19.2%
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
$0.60
Dividend growth YoY
+0.0%
Dividend growth streak
0
Last ex-dividend
2026-04-07

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-06

Profitability

9 metrics
Gross margin
54.4%
Operating margin
-20.8%
Trailing 12 months
Net margin
-5.2%
Gross profit (TTM)
$29.17M
Operating profit (TTM)
−$11.14M
Net income (TTM)
−$2.79M
Trailing 12 months
Diluted EPS (TTM)
$-0.04
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
$0.75
Gross profit per diluted share (TTM)
$0.41
Operating profit per diluted share (TTM)
$-0.15
EBITDA per diluted share (TTM)
$-0.15
Net income per diluted share (TTM)
$-0.04
Operating cash flow per diluted share (TTM)
$-0.28
Free cash flow per diluted share (TTM)
$-0.23
Capital expenditures per diluted share (TTM)
$0.00
R&D per diluted share (TTM)
$0.28
Stock compensation per diluted share (TTM)
$0.05
Book value per share
$2.78

Growth

11 metrics
Revenue growth YoY
-49.5%
Year over year
Net income growth YoY
-64.9%
Revenue (TTM)
$53.66M
Trailing 12 months
EPS growth YoY
-65.3%
Shares change YoY
+0.2%
Year over year · more shares
Revenue CAGR (3Y)
-5.1%
Revenue CAGR (5Y)
-5.4%
EPS CAGR (3Y)
-11.4%
EPS CAGR (5Y)
-14.7%
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-1.7%
Return on assets
-1.6%
Debt / equity
0.0
Current ratio
21.7
EBITDA (TTM)
−$10.55M
Free cash flow (TTM)
—
Quick ratio
16.5
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$117.58M
Latest balance sheet
Cash & equivalents
$117.58M
Total assets
$175.74M
Total debt
$0

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$20.17M
Capital expenditures (TTM)
$100,124
R&D (TTM)
$20.43M
SG&A (TTM)
$19.87M
Stock compensation (TTM)
$3.51M
R&D / revenue
38.1%
Stock compensation / revenue
6.5%

Ownership (13F)

9 metrics
13F filers
162
13F filer change QoQ
-21
Institutional ownership
48.6%
Conviction holders (share of 13F filers)
0.0%
Crowding (high-turnover and private-fund holders)
24.4%
Private-fund adviser ownership
23.6%
Active holders' share change QoQ
-0.8%
Holder tenure
15.0
Price vs estimated holder cost
-44.8%

Ownership (registered funds)

1 metrics
Index-fund ownership
8.9%

Short interest

3 metrics
Short interest
5.0%
Latest settlement · 5.2 days to cover
Days to cover
5.2d
Short-squeeze score
69 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1010086 CUSIP 826917106 13F (30d) 19 filings 19 filers Visit website Investor relations